272 related articles for article (PubMed ID: 29158282)
21. Drosophila melanogaster as a model to study virulence and azole treatment of the emerging pathogen Candida auris.
Wurster S; Bandi A; Beyda ND; Albert ND; Raman NM; Raad II; Kontoyiannis DP
J Antimicrob Chemother; 2019 Jul; 74(7):1904-1910. PubMed ID: 31225606
[TBL] [Abstract][Full Text] [Related]
22. Upc2-mediated mechanisms of azole resistance in
Li J; Aubry L; Brandalise D; Coste AT; Sanglard D; Lamoth F
Microbiol Spectr; 2024 Feb; 12(2):e0352623. PubMed ID: 38206035
[No Abstract] [Full Text] [Related]
23. An acquired mechanism of antifungal drug resistance simultaneously enables Candida albicans to escape from intrinsic host defenses.
Hampe IAI; Friedman J; Edgerton M; Morschhäuser J
PLoS Pathog; 2017 Sep; 13(9):e1006655. PubMed ID: 28953977
[TBL] [Abstract][Full Text] [Related]
24. Killing of Candida albicans by human salivary histatin 5 is modulated, but not determined, by the potassium channel TOK1.
Baev D; Rivetta A; Li XS; Vylkova S; Bashi E; Slayman CL; Edgerton M
Infect Immun; 2003 Jun; 71(6):3251-60. PubMed ID: 12761106
[TBL] [Abstract][Full Text] [Related]
25.
Romera D; Aguilera-Correa JJ; Gadea I; Viñuela-Sandoval L; García-Rodríguez J; Esteban J
J Med Microbiol; 2019 Sep; 68(9):1353-1358. PubMed ID: 31271350
[No Abstract] [Full Text] [Related]
26. How does it kill?: understanding the candidacidal mechanism of salivary histatin 5.
Puri S; Edgerton M
Eukaryot Cell; 2014 Aug; 13(8):958-64. PubMed ID: 24951439
[TBL] [Abstract][Full Text] [Related]
27. Screening a Repurposing Library for Inhibitors of Multidrug-Resistant Candida auris Identifies Ebselen as a Repositionable Candidate for Antifungal Drug Development.
Wall G; Chaturvedi AK; Wormley FL; Wiederhold NP; Patterson HP; Patterson TF; Lopez-Ribot JL
Antimicrob Agents Chemother; 2018 Oct; 62(10):. PubMed ID: 30104269
[TBL] [Abstract][Full Text] [Related]
28. Histatin 5 and human lactoferrin inhibit biofilm formation of a fluconazole resistant Candida albicans clinical isolate.
Curvelo JAR; Moraes DC; Anjos CAD; Portela MB; Soares RMA
An Acad Bras Cienc; 2019; 91(1):e20180045. PubMed ID: 30994755
[TBL] [Abstract][Full Text] [Related]
29. Human beta-defensins kill Candida albicans in an energy-dependent and salt-sensitive manner without causing membrane disruption.
Vylkova S; Nayyar N; Li W; Edgerton M
Antimicrob Agents Chemother; 2007 Jan; 51(1):154-61. PubMed ID: 17074797
[TBL] [Abstract][Full Text] [Related]
30. Genome-Wide Analysis of Experimentally Evolved Candida auris Reveals Multiple Novel Mechanisms of Multidrug Resistance.
Carolus H; Pierson S; Muñoz JF; Subotić A; Cruz RB; Cuomo CA; Van Dijck P
mBio; 2021 Apr; 12(2):. PubMed ID: 33820824
[No Abstract] [Full Text] [Related]
31. Candida auris and multidrug resistance: Defining the new normal.
Lockhart SR
Fungal Genet Biol; 2019 Oct; 131():103243. PubMed ID: 31228646
[TBL] [Abstract][Full Text] [Related]
32. The Two-Component Response Regulator Ssk1 and the Mitogen-Activated Protein Kinase Hog1 Control Antifungal Drug Resistance and Cell Wall Architecture of Candida auris.
Shivarathri R; Jenull S; Stoiber A; Chauhan M; Mazumdar R; Singh A; Nogueira F; Kuchler K; Chowdhary A; Chauhan N
mSphere; 2020 Oct; 5(5):. PubMed ID: 33055262
[No Abstract] [Full Text] [Related]
33. Studies of the mechanism of human salivary histatin-5 candidacidal activity with histatin-5 variants and azole-sensitive and -resistant Candida species.
Tsai H; Bobek LA
Antimicrob Agents Chemother; 1997 Oct; 41(10):2224-8. PubMed ID: 9333052
[TBL] [Abstract][Full Text] [Related]
34.
Maphanga TG; Mpembe RS; Naicker SD; Govender NP;
Microbiol Spectr; 2022 Feb; 10(1):e0171721. PubMed ID: 35196811
[TBL] [Abstract][Full Text] [Related]
35. High frequency of azole resistant Candida spp. colonization among presumptive multidrug resistant tuberculosis (MDR-TB) patients.
Darma S; Ambara A; Aman AT; Annisa L; Nurrokhman ; Nuryastuti T; Wibawa T
PLoS One; 2020; 15(11):e0242542. PubMed ID: 33212470
[TBL] [Abstract][Full Text] [Related]
36. A multicentre study of antifungal susceptibility patterns among 350 Candida auris isolates (2009-17) in India: role of the ERG11 and FKS1 genes in azole and echinocandin resistance.
Chowdhary A; Prakash A; Sharma C; Kordalewska M; Kumar A; Sarma S; Tarai B; Singh A; Upadhyaya G; Upadhyay S; Yadav P; Singh PK; Khillan V; Sachdeva N; Perlin DS; Meis JF
J Antimicrob Chemother; 2018 Apr; 73(4):891-899. PubMed ID: 29325167
[TBL] [Abstract][Full Text] [Related]
37. Amphotericin B- and fluconazole-resistant Candida spp., Aspergillus fumigatus, and other newly emerging pathogenic fungi are susceptible to basic antifungal peptides.
Helmerhorst EJ; Reijnders IM; van't Hof W; Simoons-Smit I; Veerman EC; Amerongen AV
Antimicrob Agents Chemother; 1999 Mar; 43(3):702-4. PubMed ID: 10049295
[TBL] [Abstract][Full Text] [Related]
38. Salivary histatin 5 induces non-lytic release of ATP from Candida albicans leading to cell death.
Koshlukova SE; Lloyd TL; Araujo MW; Edgerton M
J Biol Chem; 1999 Jul; 274(27):18872-9. PubMed ID: 10383383
[TBL] [Abstract][Full Text] [Related]
39. Released ATP is an extracellular cytotoxic mediator in salivary histatin 5-induced killing of Candida albicans.
Koshlukova SE; Araujo MW; Baev D; Edgerton M
Infect Immun; 2000 Dec; 68(12):6848-56. PubMed ID: 11083804
[TBL] [Abstract][Full Text] [Related]
40. Salivary histatin 5 and human neutrophil defensin 1 kill Candida albicans via shared pathways.
Edgerton M; Koshlukova SE; Araujo MW; Patel RC; Dong J; Bruenn JA
Antimicrob Agents Chemother; 2000 Dec; 44(12):3310-6. PubMed ID: 11083633
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
